NCT01224587View on ClinicalTrials.gov

Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Magnetic Marker MonitoringGastrointestinal-transportGastric Emptying TimeSmall Intestinal Transit TimeTime for Colon ArrivalFood Effect
Interventions
DRUG

D1000078

Oral, one single dose

DRUG

D1000082

Oral, one single dose

DRUG

D1000083

Oral, one single dose

DRUG

D1000085

Oral, one single dose

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY